Docetaxel for Advanced Gastric Cancer?-Reference-Cited by-同舟云学术

Docetaxel for Advanced Gastric Cancer?

Published:2007-06-10 Issue:17 Volume:25 Page:2490-2491
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Wagner Anna D.¹,Wedding Ulrich²,Kuss Oliver³,Höffken Klaus²

Affiliation:

1. Department of Internal Medicine II, University Hospital, Friedrich-Schiller-University Jena, Germany; Coordinating Centre for Clinical Trials, Martin-Luther-University Halle-Wittenberg, Germany

2. Department of Internal Medicine II, University Hospital, Friedrich-Schiller-University Jena, Germany

3. Institute of Medical Epidemiology, Biostatistics and Informatics, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2007.10.9314

Reference11 articles.

1. Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group

2. Al Batran S, Hartman J, Probst S, et al: A randomized phase III trial in patients with advanced adenocarcinoma of the stomach receiving first-line chemotherapy with fluorouracil, leucovorin and oxaliplatin (FLO) versus fluorouracil, leucovorin and cisplatin (FLP). J Clin Oncol 24:182s,2006, (LBA 4016)

3. Cunningham D, Rao D, Starling N, et al: Randomised multicenter phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric (OG) cancer: The REAL-2 trial. J Clin Oncol 24:182s,2006, (abstr 4017)

4. Ohtsu A, Shimada Y, Shirea V, et al: Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205). J Clin Oncol 21:54,2004-59,

5. End Points and United States Food and Drug Administration Approval of Oncology Drugs

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maligne Erkrankungen des Gastrointestinaltrakts bei alten Patienten;Der Gastroenterologe;2012-06-14

2. Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma;Cancer Chemotherapy and Pharmacology;2010-03-17

3. Is There an Optimal Chemotherapy Regimen for the Treatment of Advanced Gastric Cancer That Will Provide a Platform for the Introduction of New Biological Agents?;The Oncologist;2008-07-01

4. Locally Advanced and Metastatic Gastric Cancer;Drugs;2008